According to Sanofi India Limited's latest financial reports the company has A$60.82 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | A$63.71 M | -8.39% |
2023-12-31 | A$69.55 M | -61.02% |
2022-12-31 | A$0.17 B | -37.39% |
2021-12-31 | A$0.28 B | 33.86% |
2020-12-31 | A$0.21 B | -5.07% |
2019-12-31 | A$0.22 B | 33.91% |
2018-12-31 | A$0.16 B | 14.4% |
2017-12-31 | A$0.14 B | 29.58% |
2016-12-31 | A$0.11 B | -3.45% |
2015-12-31 | A$0.11 B | 30.66% |
2014-12-31 | A$89.57 M | 89.99% |
2013-12-31 | A$47.14 M | -37.3% |
2012-12-31 | A$75.19 M | 74.95% |
2011-12-31 | A$42.98 M | -78.55% |
2010-12-31 | A$0.20 B | 14.47% |
2009-12-31 | A$0.17 B | 19.35% |
2008-12-31 | A$0.14 B | 28.83% |
2007-12-31 | A$0.11 B | 2.94% |
2006-12-31 | A$0.11 B | 23.69% |
2005-12-31 | A$89.4 M | 79.1% |
2004-12-31 | A$49.92 M |